Cytodyn Inc (CYDY)

[DonDonDonDon]

If there were more deaths with Leronlimab would you also not deduce that the FDA would stop ALL use of Leronlimab? Since the FDA has allowed the trials and outside trial usage to continue would it not be better to deduce that Leronlimab performed totally opposite of what you falsely deduced? Or are you saying that the FDA is killing people by allowing Leronlimab to continue?

If leronimab has a positive mortality benefit with severe patients, we would know it. The FDA isn't going to stop anything for a small mortality disbenefit. The DSMB might have recommended stopping the trial for futility but obviously Nader wouldn't follow that guidance.